Abstract: The invention is directed to a method for producing non-oxide semiconductor nanoparticles, the method comprising: (a) subjecting a combination of reaction components to conditions conducive to microbially-mediated formation of non-oxide semiconductor nanoparticles, wherein said combination of reaction components comprises i) anaerobic microbes, ii) a culture medium suitable for sustaining said anaerobic microbes, iii) a metal component comprising at least one type of metal ion, iv) a non-metal component containing at least one non-metal selected from the group consisting of S, Se, Te, and As, and v) one or more electron donors that provide donatable electrons to said anaerobic microbes during consumption of the electron donor by said anaerobic microbes; and (b) isolating said non-oxide semiconductor nanoparticles, which contain at least one of said metal ions and at least one of said non-metals.
Type:
Grant
Filed:
February 3, 2009
Date of Patent:
June 24, 2014
Assignees:
UT-Battelle, LLC, University of Tennessee Research Foundation
Inventors:
Tommy J. Phelps, Robert J. Lauf, Ji Won Moon, Adam J. Rondinone, Lonnie J. Love, Chad Edward Duty, Andrew Stephen Madden, Yiliang Li, Ilia N. Ivanov, Claudia Jeanette Rawn
Abstract: A switching circuit according to one embodiment is a switching circuit including at least one semiconductor switch element having an input, output, and a common terminals, a pulse-like signal being applied between the input and common terminals to switch a current between the output and common terminals. The switching circuit further includes a capacitance suppression element section connected at least one of between the input and output terminals, between the input terminal common terminals, and between the output and common terminals. The capacitance suppression element section reduces a parasitic capacitance between the terminals of the semiconductor switch element where the capacitance suppression element section is connected to less than that obtained when the capacitance suppression element section is not connected at a frequency N times (N is an integer of 1 or more) as high as a clock frequency of the pulse-like signal.
Type:
Grant
Filed:
June 6, 2012
Date of Patent:
June 24, 2014
Assignees:
Sumitomo Electric Industries, Ltd., National University Corporation Toyohashi University of Technology
Abstract: A blue phase liquid crystal material includes a liquid crystal host, a chiral reagent and a stable polymer. The chiral reagent is R811. The stable polymer is formed by photo-polymerizing a first monomer and a second monomer. The first monomer is 2-ethylhexyl acrylate (2-EHA), and the second monomer is 2-methyl-1,4-bis{4-[3(-acrylate)propoxyl]benzoicacid}phenylester (PTPTP). The blue phase liquid crystal material has a blue phase temperature range widened to an extremely low temperature. A blue phase liquid crystal composition and a method for manufacturing the blue phase liquid crystal material by using the blue phase liquid crystal composition are also provided.
Type:
Grant
Filed:
November 1, 2012
Date of Patent:
June 24, 2014
Assignees:
Infovision Optoelectronics (Kunshan) Co., Ltd., East China University of Science and Technology
Abstract: Methods and compositions for natural product optimization are provided. In particular, methods and compositions for selecting bacterial strains (e.g., predatory bacteria such as myxobacteria) which produce a desired compound (e.g., antibiotic, antifungal, or anticancer agent) are provided.
Abstract: In a multicore fiber in which multiple single mode cores are stored in one optical fiber, the multicore fiber has a lattice-point arrangement in which multiple lattice points are periodically arranged two-dimensionally with translational symmetry and rotational symmetry or one of translational symmetry and rotational symmetry and, in that lattice-point arrangement, multiple cores are arranged with the lattice points of the lattice-point arrangement as reference positions. By giving different perturbations to the propagation constants of the cores, the propagation constants of the cores are each varied from the original propagation constants. Because of the variation in the propagation constants, the core-to-core coupling amount, which is dependent on the varied propagation constants, fall below a predetermined setting amount.
Type:
Grant
Filed:
August 23, 2011
Date of Patent:
June 24, 2014
Assignee:
National University Corporation Yokohama National University
Abstract: The present invention relates to an enzyme determining amino acid sequences of an enzyme involved in pyrethrin biosynthesis and a base sequence of the gene thereof; constructing vectors bearing the gene and transformants; and extractable from plant bodies producing pyrethrin by applying such creative techniques to plant bodies with faster growth aiming to provide a method to efficiently produce pyrethrin; and the enzyme is a gene encoding a protein of the following (i) or (ii) or (iii): (i) a protein consisting of an amino acid sequence shown in Sequence No. 1; or (ii) a protein consisting of an amino acid sequence shown in Sequence No. 5, or a protein consisting of an amino acid sequence shown in Sequence No. 6, or a protein consisting of an amino acid sequence shown in Sequence No. 7, or a protein consisting of an amino acid sequence shown in Sequence No.
Type:
Grant
Filed:
August 5, 2011
Date of Patent:
June 24, 2014
Assignees:
An Educational Foundation Kinki University, Dainihon Jochugiku Co., Ltd.
Abstract: A method, computer implemented method and associated apparatus for the management of diabetes comprises utilizing zone model predictive control (Zone-MPC) to control delivery of an insulin or insulin analog within a zone of desired values.
Type:
Grant
Filed:
February 11, 2011
Date of Patent:
June 24, 2014
Assignees:
Regents of the University of California, Sansum Diabetes Research Institute
Inventors:
Francis J. Doyle, III, Benyamin Grosman, Eyal Dassau, Lois Javanovic, Howard Zisser
Abstract: The object of the present invention is to provide a method of determining the dose and/or administration of statins to a patient suffering from a cardiovascular disease. The object is achieved by the method of determining the dose and/or administration of statins to a patient suffering from a cardiovascular disease comprising Step (1) of measuring the intracellular SmgGDS expression level of a patient suffering from a cardiovascular disease before and after administration of statin; and Step (2) of determining the type and/or the dose of statin for the patient in reference to the SmgGDS expression level measured in the Step (1).
Abstract: A probe including a housing, a rectal muscle air bag, a rectal tube, an anal muscle air bag, and an anal tube is provided. The rectal muscle air bag mounts to the housing a first distance from a non-insertion end. A rectal tube is connected to the rectal muscle air bag at a first end and to a first pressure sensor at a second end. The anal muscle air bag is mounted to the housing a second distance from the non-insertion end. The anal tube is connected to the anal muscle air bag at a first end and to a second pressure sensor at a second end. The first distance is selected to position the rectal muscle air bag adjacent a rectal muscle, and the second distance is selected to position the anal muscle air bag adjacent an anal muscle when the housing is inserted in the rectum.
Abstract: The methanol electro-oxidation catalysts include nano-oxides of rare earth metals (i.e., cesium, praseodymium, neodymium and samarium) and platinum nano-particles. The nano-oxides of the rare earth metals are dispersed during synthesis of a support material, preferably formed from mesoporous carbon. The platinum nano-particles form between about 10 wt % and about 15 wt % of the methanol electro-oxidation catalyst, the rare earth metal forms between about 10 wt % and about 15 wt % of the methanol electro-oxidation catalyst, and carbon and oxygen forming the balance (between about 70 wt % and about 80 wt %) of the methanol electro-oxidation catalyst.
Type:
Grant
Filed:
December 27, 2011
Date of Patent:
June 24, 2014
Assignee:
King Fahd University of Petroleum and Minerals
Inventors:
Syed Mohammed Javaid Zaidi, Saleem Ur Rahman, Shakeel Ahmed, Mukhtar Bello
Abstract: The present invention relates to an antibody that recognizes a first antibody, the antibody specifically recognizing one of a free first antibody and an antigen-binding first antibody. More specifically, the above antibody is a domino antibody that specifically recognizes and binds to an antigen-binding first antibody, or an antibody-unlocking antibody that specifically recognizes and binds to a free first antibody.
Type:
Grant
Filed:
August 24, 2011
Date of Patent:
June 24, 2014
Assignees:
Otsuka Pharmaceutical Co., Ltd., Tokyo University of Science
Abstract: The present invention provides a hydrophobic group-introduced hyaluronic acid derivative comprising at least one repeating unit represented by the formula (I): wherein R1, R2, R3, R4, Z, n, Ra, Y, and X1 are as defined in the specification.
Type:
Grant
Filed:
November 5, 2009
Date of Patent:
June 24, 2014
Assignees:
National University Corporation Tokyo Medical and Dental University, Chugau Seiyaku Kabushiki Kaisha
Inventors:
Kazunari Akiyoshi, Takashi Nakai, Tai Hirakura, Tsuyoshi Shimoboji
Abstract: A method for laying carbon nanotube film includes following steps. A carbon nanotube film is provided. The carbon nanotube film includes a number of carbon nanotube strings substantially parallel to each other and extending along a first direction. The carbon nanotube film is stretched along a second direction substantially perpendicular with the first direction to form a deformation along the second direction. The carbon nanotube film is placed on a surface of a substrate. The deformation along the second direction is kept.
Type:
Grant
Filed:
October 29, 2012
Date of Patent:
June 24, 2014
Assignees:
Tsinghua University, Hon Hai Precision Industry Co., Ltd.
Inventors:
Kai-Li Jiang, Chen Feng, Lin Xiao, Zhuo Chen, Liang Liu, Shou-Shan Fan, Qun-Qing Li, Li Qian, Yang Wei
Abstract: Disclosed are a construct for expressing a rotavirus antigen complex loaded with a heterologous virus epitope, a vaccine composition containing the rotavirus antigen complex, a virus-like particle of rotavirus containing the rotavirus antigen complex, and a vaccine composition containing the virus-like particle of rotavirus. According to the present disclosure, an antigen complex containing a rotavirus antigen as well as a heterologous virus epitope and a virus-like particle of rotavirus containing the antigen complex can be produced in large scale at low cost. Thus, the present disclosure may be applied for research and development of novel complex vaccines for rotavirus and heterologous virus.
Type:
Grant
Filed:
April 27, 2011
Date of Patent:
June 24, 2014
Assignee:
Chung-Ang University Industry-Academy Cooperation Foundation
Inventors:
Won Yong Kim, In Sik Chung, Jong-Bum Kim, Dong-Hwa Shon, Van Thai Than, Jang Won Yoon, Joo Hyoung Park, In-Hyuk Baek
Abstract: The present invention is directed to a method of regulating gastrointestinal action in a subject using a stimulatory electrode and a sensor to provide retrograde feedback control of electrical stimulation to the GI tract.
Type:
Grant
Filed:
March 2, 2007
Date of Patent:
June 24, 2014
Assignee:
The Board of Regents of the University of Texas
Abstract: A dental clinical apparatus having a function which conventional instruments for dental treatment have not had and having a novel constitution. The dental clinical apparatus includes a syringe which has a fluid jetting system for dental treatment and a plasma jet applying means for producing a plasma jet from the end by allowing a low-frequency high-voltage power supply to apply a low-frequency high voltage between electrodes on the outer peripheral surface of a rare gas tube through which a rare gas having a low dielectric breakdown voltage under the atmospheric pressure is flowed, and thereby causing electrical discharge.
Type:
Grant
Filed:
July 17, 2009
Date of Patent:
June 24, 2014
Assignees:
Yoshida Creation Inc., Osaka University, Technology Research Institute of Osaka Prefecture
Abstract: Methods for fabricating waveguides in conjunction with interconnect fabrication in back-ends of integrated circuits and structures thereof are disclosed. One method for forming a waveguide in accordance with one embodiment of the disclosure comprises selectively etching a dielectric layer and forming of a core region of a waveguide at a back-end of an integrated circuit. The dielectric layer is material deposited during a cycle of fabrication of the back-end of the integrated circuit. The method further includes depositing a material having a dielectric constant that is suitable to be the core region of the waveguide cladded by the dielectric layer over the dielectric layer and into the etched feature for the core region of the waveguide, and planarizing a surface of the material.
Type:
Grant
Filed:
December 8, 2010
Date of Patent:
June 24, 2014
Assignee:
University of Washington through its Center for Commercialization
Abstract: The invention relates to, in part, secreted proteins of bacterial pathogens and methods for their use. More specifically, the invention provides in part several new common secreted proteins for A/E pathogens. In some embodiments of the invention, these polypeptides and nucleic acid molecules encoding these polypeptides, or portions thereof, are useful as vaccines, diagnostics, or drug screening tools for A/E pathogenic infections, or as reagents.
Type:
Grant
Filed:
October 29, 2004
Date of Patent:
June 24, 2014
Assignees:
The University of British Columbia, Universidad Nacional Autonoma de Mexico
Inventors:
Brett Finlay, Samantha Gruenheid, Wanyin Deng, Bruce A. Vallance, Jose L. Puente